Mediterranean anemia with other hemoglobinopathy)
Maternal thalassemia in childbirth
Maternal thalassemia in pregnancy
Postpartum after childbirth) maternal thalassemia
Thalassemia
Thalassemia in pregnancy
Thalassemia postpartum
A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.
An inherited blood disorder characterized by a decreased synthesis of one of the polypeptide chains that form hemoglobin. Anemia results from this abnormal hemoglobin formation.
An inherited form of anemia
Heterogeneous group of hereditary hemolytic anemias which have in common a decreased rate of synthesis of one or more hemoglobin polypeptide chains.
If you have thalassemia, your body has problems making hemoglobin, the protein in red blood cells that carries oxygen through your body. When your blood does not carry enough oxygen to the rest of your body, you have anemia.thalassemia, a genetic disease, can be mild or severe. Some carriers of the gene have no symptoms. The most common severe form in the United States is a type called cooley’s anemia. It mainly affects people of mediterranean or asian ancestry. It usually appears during the first two years of life. Severe thalassemia is treated with blood transfusions and treatment to remove excess iron in the blood.
D56.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2023 edition of ICD-10-CM D56.9 became effective on October 1, 2022.
This is the American ICD-10-CM version of D56.9 – other international versions of ICD-10 D56.9 may differ.